MSFT vs. RIGL
MSFT (Microsoft Corporation) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. MSFT operates in Software - Infrastructure (Technology), while RIGL operates in Biotechnology (Healthcare). Over the past 10 years, MSFT returned 24.64%/yr vs 2.33%/yr for RIGL. At a 0.25 correlation, their price movements are largely independent.
Performance
MSFT vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MSFT achieves a -14.48% return, which is significantly higher than RIGL's -29.77% return. Over the past 10 years, MSFT has outperformed RIGL with an annualized return of 24.64%, while RIGL has yielded a comparatively lower 2.33% annualized return.
MSFT
- 1D
- -1.18%
- 1M
- -0.60%
- YTD
- -14.48%
- 6M
- -15.77%
- 1Y
- -11.77%
- 3Y*
- 8.85%
- 5Y*
- 11.09%
- 10Y*
- 24.64%
RIGL
- 1D
- 0.50%
- 1M
- 15.51%
- YTD
- -29.77%
- 6M
- -30.69%
- 1Y
- 39.97%
- 3Y*
- 23.16%
- 5Y*
- -5.96%
- 10Y*
- 2.33%
MSFT vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MSFT Microsoft Corporation | -14.48% | 15.58% | 12.93% | 58.19% | -28.02% | 52.48% | 42.53% | 57.56% | 20.80% | 40.73% |
RIGL Rigel Pharmaceuticals, Inc. | -29.77% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
Correlation
The correlation between MSFT and RIGL is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Nov 29, 2000 | 0.25 |
Over the past year, the correlation between MSFT and RIGL has dropped to 0.03 - well below their long-term average of 0.25, suggesting their price drivers have been diverging.
Fundamentals
MSFT:
$3.07T
RIGL:
$592.15M
MSFT:
$16.79
RIGL:
$19.21
MSFT:
24.52
RIGL:
1.57
MSFT:
1.72
RIGL:
0.00
MSFT:
9.65
RIGL:
1.90
MSFT:
7.40
RIGL:
1.48
MSFT:
$318.27B
RIGL:
$299.77M
MSFT:
$217.41B
RIGL:
$279.95M
MSFT:
$200.96B
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MSFT vs. RIGL — Risk / Return Rank
MSFT
RIGL
MSFT vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Microsoft Corporation (MSFT) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MSFT | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.04 | ||
| Sortino ratioReturn per unit of downside risk | -1.89 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.17 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | -0.35 | 0.80 | -1.15 |
| Martin ratioReturn relative to average drawdown | -0.73 | 1.41 | -2.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MSFT | RIGL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.47 | 0.58 | -1.04 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | -0.07 | +0.49 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.91 | 0.03 | +0.89 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.74 | -0.13 | +0.87 |
Drawdowns
MSFT vs. RIGL - Drawdown Comparison
The maximum MSFT drawdown since its inception was -69.38%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for MSFT and RIGL.
Loading charts...
Drawdown Indicators
| MSFT | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.38% | -99.37% | +29.99% |
Max Drawdown (1Y)Largest decline over 1 year | -33.91% | -50.08% | +16.17% |
Max Drawdown (3Y)Largest decline over 3 years | -33.91% | -57.75% | +23.84% |
Max Drawdown (5Y)Largest decline over 5 years | -37.15% | -85.24% | +48.09% |
Max Drawdown (10Y)Largest decline over 10 years | -37.15% | -86.40% | +49.25% |
Current DrawdownCurrent decline from peak | -23.56% | -97.18% | +73.62% |
Average DrawdownAverage peak-to-trough decline | -21.78% | -90.92% | +69.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.13% | 28.34% | -12.21% |
Volatility
MSFT vs. RIGL - Volatility Comparison
The current volatility for Microsoft Corporation (MSFT) is 10.25%, while Rigel Pharmaceuticals, Inc. (RIGL) has a volatility of 18.26%. This indicates that MSFT experiences smaller price fluctuations and is considered to be less risky than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MSFT | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.25% | 18.26% | -8.01% |
Volatility (6M)Calculated over the trailing 6-month period | 22.36% | 38.39% | -16.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.31% | 69.94% | -44.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.64% | 85.50% | -58.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.06% | 82.83% | -55.77% |
Dividends
MSFT vs. RIGL - Dividend Comparison
MSFT's dividend yield for the trailing twelve months is around 0.86%, while RIGL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MSFT Microsoft Corporation | 0.86% | 0.70% | 0.73% | 0.74% | 1.06% | 0.68% | 0.94% | 1.20% | 1.69% | 1.86% | 2.37% | 2.33% |
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MSFT vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Microsoft Corporation and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MSFT vs. RIGL - Profitability Comparison
MSFT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Microsoft Corporation reported a gross profit of 56.06B and revenue of 82.89B. Therefore, the gross margin over that period was 67.6%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
MSFT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Microsoft Corporation reported an operating income of 38.40B and revenue of 82.89B, resulting in an operating margin of 46.3%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
MSFT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Microsoft Corporation reported a net income of 31.78B and revenue of 82.89B, resulting in a net margin of 38.3%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
MSFT and RIGL have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RIGL has higher volatility (18.26%) compared to MSFT (10.25%). In terms of maximum drawdown, MSFT dropped -69.38% vs RIGL's -99.37%.
RIGL currently has the higher Sharpe Ratio (0.58 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MSFT and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer